Skip to main content
Caplight Logo









Lundbeckfonden BioCapital

Lundbeckfonden BioCapital

Copenhagen, Capital Region of Denmarklundbeckfonden.com

Overview

Lundbeckfonden BioCapital is the venture capital arm of the Lundbeck Foundation. It operates as an evergreen fund that invests in life science companies, primarily those based in Denmark, to support the translation and commercialization of new scientific research. It was formed by combining the foundation's previous investment units, Lundbeckfonden Ventures and Lundbeckfonden Emerge. The fund invests across all therapeutic areas and stages of development. Lundbeckfonden Emerge, its predecessor, was the foundation's early-stage, evergreen investment unit focused on building and financing biotech companies based on Danish research.

Portfolio Companies

13

Investments

Lundbeckfonden BioCapital investments
CompanyDateStageLead
Spero BiopharmaMar 2017Series CCo-investor
Sorriso PharmaceuticalsDec 2021Series ACo-investor
Epoqe PharmaJan 2025SeedLead
Folium Science-SeedLead
Cytoki PharmaMay 2021Series ALead
Book a demo to see all 13 portfolio companies

For institutional investors. Book with your work email.

Key People

Kevin Dolowy Dalgaard

Senior Principal

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Portfolio analytics

Caplight clients see full sector, stage and valuation breakdowns for this investor.

Book a demo to see full analytics

For institutional investors. Book with your work email.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Portfolio analytics

Caplight clients see yearly investment pace and funding raised over time.

Book a demo to see full analytics

For institutional investors. Book with your work email.

FAQ

Where is Lundbeckfonden BioCapital based?

Lundbeckfonden BioCapital is headquartered in Copenhagen, Capital Region of Denmark, Denmark.

When was Lundbeckfonden BioCapital founded?

Founding year information for Lundbeckfonden BioCapital is not publicly available.

How many portfolio companies does Lundbeckfonden BioCapital have?

Lundbeckfonden BioCapital has 13 portfolio companies in Caplight's dataset.

What are some companies in Lundbeckfonden BioCapital's portfolio?

Portfolio companies visible on Caplight include Spero Biopharma, Sorriso Pharmaceuticals, Epoqe Pharma, Folium Science, Cytoki Pharma.

What was Lundbeckfonden BioCapital's most recent investment shown here?

Lundbeckfonden BioCapital's most recent investment in this portfolio sample was in Epoqe Pharma in 2025.

What sectors does Lundbeckfonden BioCapital focus on?

Lundbeckfonden BioCapital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Frontier & Industrial Tech, Frontier & Industrial Tech.

What company stages does Lundbeckfonden BioCapital focus on?

Lundbeckfonden BioCapital typically invests at the Early stage.

Firmographic Details

HeadquartersCopenhagen, Capital Region of Denmark
Year FoundedN/A

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?